Home / News (page 2613) /


Supreme Court dismisses fraud-on-the-FDA claims

Reversing a decision by the U.S. Court of Appeals for the Third Circuit (159 F.3d 817), the U.S. Supreme Court’s February 21 decision concluded that plaintiffs’ fraud-on-the-FDA claims were pre-empted by federal regulation. Buckman Company vs. Plaintiffs’ Legal Committee, No. ...

Read More »